|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
6/2008
vol. 7 abstract:
Thromboembolic safety of transdermal hormone therapy
Grzegorz Stachowiak
,
Tomasz Pertyński
Przegląd Menopauzalny 2008; 6: 285-290
Online publish date: 2009/01/05
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
This article is a review of up-to-date reports – the newest references and own studies – on the influence of transdermal hormone therapy (HT) on thromboembolic risk in menopausal women. The available data testify clearly to the high thromboembolic safety of HT, even when this therapy is administered in women with thromboembolic risk factors.
keywords:
menopause, transdermal hormone therapy, thromboembolic complications |
 |
